drugset / Trial / NCT04780152

TDCS in Pediatric and Teenage Patients With Major Depressive Disorder During COVID-19 Pandemic

NCT04780152

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to assess safety and efficacy of nodal transcranial direct current stimulation in pediatric and teenager population with major depressive disorder in the COVID-19 pandemic.

Timeline

Start
2021-10
Primary completion
2022-08
Completion
2022-09

Publications

Drugs

EvaluationDrugModalityDoseRoute
Background Fluoxetine Small molecule 20 mg